SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181162-04-000001
Filing Date
2004-01-20
Accepted
2004-01-20 09:16:16
Documents
1
Period of Report
2003-05-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 2863
  Complete submission text file 0001181162-04-000001.txt   4660
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address
Business Address PHARMACEUTICAL PRODUCT DEVELOPMENT INC 3151 S 17TH ST WILMINGTON DE 28412 9102510081
STAUB W RICHARD (Reporting) CIK: 0001181162 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-27570 | Film No.: 04531061